MedicineNet.com
MedicineNet home Picture Slideshows Diseases and conditions Symptoms and signs Procedures and tests Medications Health and Living Health news and views MedTerms medical dictionary
Font Size
A
A
A


Medication Written by Pharmacists Reviewed by Doctors

GENERIC NAME: nateglinide

BRAND NAME: Starlix

DRUG CLASS AND MECHANISM: Nateglinide is an oral drug used to lower blood sugar (glucose) levels in type 2 diabetes. It is in a class of drugs called meglitinides which also includes repaglinide (Prandin). Approximately 90% of patients with diabetes have type 2 diabetes. Type 2 diabetes usually occurs in adults and is associated with obesity and a strong family history of diabetes. Insulin is an important hormone that controls the blood level of glucose. Type 2 diabetics have an inability to control blood glucose levels. This is caused by reduced secretion of insulin from the pancreas after meals and resistance of the body's cells to the effect of insulin which is to stimulate the cells to remove glucose from the blood. This leads to high levels of blood glucose. Nateglinide stimulates cells in the pancreas to produce insulin in a manner similar to the class of drugs called sulfonylureas, e.g., glyburide (Diabeta, Glynase and Micronase) which also are used in type 2 diabetes. However, nateglinide appears to have a faster onset and a shorter duration of action than sulfonylureas. The benefit of this faster, shorter effect may be to prevent the rapid, transient rise in blood glucose that occurs in diabetics immediately following a meal. Nateglinide was approved by the FDA in December, 2000.

GENERIC: no

PRESCRIPTION: yes

PREPARATIONS: Tablet: 60 and 120 mg.

STORAGE: Nateglinide should be stored at room temperature, 15-30°C(59-86°F) in an air-tight container.

PRESCRIBED FOR: Nateglinide is used to control blood glucose levels in type 2 diabetes. It may be used with diet and exercise when diet and exercise alone are not successful in controlling blood glucose. It also may be used with metformin, another drug that is used for controlling blood glucose in type 2 diabetes. Nateglinide is not recommended if blood glucose levels have not been controlled by a sulfonylurea since nateglinide and sulfonylureas have a similar mechanism of action. Therefore, if sulfonylureas are ineffective, it is likely that nateglinide also will be ineffective.

DOSING: Nateglinide may be prescribed at 60 or 120 mg three times daily. The dose is adjusted depending upon blood glucose and HbA1c levels. Nateglinide should be taken 30 minutes or less before a meal but should not be taken if a meal is skipped.

DRUG INTERACTIONS: Starting or stopping the following drugs may increase the response to nateglinide and may require the dose of nateglinide to be lowered: non-steroidal anti-inflammatory agents (NSAIDs) like ibuprofen (Motrin, etc.), aspirin and aspirin-like compounds, monoamine oxidase inhibitors like phenelzine (Nadril), and beta-blocking drugs like propranolol (Inderal). Starting or stopping the following drugs may decrease the response to nateglinide and may require the dose of nateglinide to be increased: thiazide diuretics like hydrochlorothiazide, steroids like prednisone, thyroid hormone like levothyroxine, and drugs used in emergencies to regulate the heartbeat or restore breathing when airways are blocked. Examples of these latter drugs are epinephrine and albuterol (Ventolin).

PREGNANCY: No safety and efficacy studies have been conducted in pregnant women taking nateglinide.

NURSING MOTHERS: No safety and efficacy studies have been conducted in pregnant women taking nateglinide.

SIDE EFFECTS: Development of a runny nose, cough, and flu-like symptoms is the most common side effect seen with nateglinide therapy. Hypoglycemia (low blood glucose levels with or without symptoms), dizziness and joint pain may occur.
Last Editorial Review: 9/9/2001 12:48:00 PM




Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Printer-Friendly Format  |  Email to a Friend


Suggested Reading by Our Doctors
MedicineNet Doctors
  • repaglinide, Prandin -
  • Diabetes - Learn about type 1 and 2 diabetes (Diabetes Mellitus) symptoms including increased urination, thirst, weight loss, fatigue, nausea, vomiting, skin infections, and blurred vision. Causes and diagnosis information is provided in the information.
  • Diabetes Treatment - Learn about the different treatments for diabetes including: medications, insulin, insulin pumps, inhaled insulin, and insulin pens.

Latest Medical News


Back to Medications Index

Diabetes

Find tips and advances in treatment.




Symptoms & Signs A-Z List Pinpoint Your Symptoms - Start Now Symptoms & Signs A-Z List Symptoms & Signs by Female Body Region Symptoms & Signs by Male Body Region

Topics Related to nateglinide, Starlix


nateglinide
RSS FeedSpecialty RSS       Add to My Yahoo! What is this?



Related Drugs - WebMD Health Network




Top 3
nateglinide, Starlix Related Articles







Health categories:

Slideshows | Diseases & Conditions | Symptoms & Signs | Procedures & Tests | Medications | Health & Living | News & Views | Medical Dictionary

Popular health centers:

Allergies | Arthritis | Cancer | Diabetes | Digestion | Healthy Kids | Heart | Men's Health | Mental Health | Women's Health | More...

Publications:

ePublications (PDFs) | XML News via RSS | Audio Podcasts | Email Newsletters

MedicineNet.com:

About Us | Privacy Policy | Search Help | Site Map | WebMD® | Medscape® | eMedicine® | eMedicineHealth® | RxList®

This website is certified by Health On the Net Foundation. Click to verify. This site complies to the HONcode standard for trustworthy health information:
verify here.

©1996-2009 MedicineNet, Inc. All rights reserved. Notices and Legal Disclaimer.
MedicineNet does not provide medical advice, diagnosis or treatment. See additional information.